comprehensive -WSS

comprehensive

author：fashion 2025-10-02 21:36:14 - browse：8919

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： FDA approves Moderna’s RSV vaccine, its second licensed product

WSS

After half a century, Israel moves to evict squatter from his cave home on the beach

How CO2 helps viruses stay alive longer in the air

Stopping antidepressants leads to symptoms for 1 in 6 patients

Blinken talks high

France's anti

Grail's uphill battle for Medicare to cover its cancer screening test

hotspot

comprehensive

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Grail's uphill battle for Medicare to cover its cancer screening test

In Memoriam: Notable people who died in 2023

STAT wants to know your pick for a great summer read or listen

Dobbs anniversary: the lost opportunity of abortion as health care

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

In age of alternative facts, a scholarly course on calling out crap

Senators tussle over abortion against the backdrop of a presidential campaign

Wikipedia

Companies helping big Covid

FTC loses bid to block Novant's North Carolina hospital merger

A Greenpeace activist is fined for crash

STAT wants to know your pick for a great summer read or listen

'Little Tech' descents on D.C., wanting a say in how AI is regulated

France's anti

hotspot

hotspot

knowledge

leisure time